Stem Cells For The Brain
Show notes
In this 131st episode of Sober Head Podcast, Dr. Esra Çavuşoğlu, PhD welcomes Dr. Vincent Giampapa, MD.
Dr. Vincent Giampapa is an American physician, plastic and reconstructive surgeon, and researcher recognized for his pioneering work in regenerative and anti-aging medicine. A co-founder of the American Academy of Anti-Aging Medicine (A4M), he focuses on stem cell therapies, cellular regeneration, and the biology of aging. Combining medicine and biotechnology, he is widely regarded as one of the leading figures in the field of longevity.
Can we slow down brain aging—or perhaps even reverse it one day? In this episode of SoberHead Podcast, I sit down with Dr. Vincent Giampapa to explore emerging research into brain rejuvenation, cognitive decline, and the future of longevity medicine.
Could stem cells, gene therapy, focused ultrasound, and exosomes help protect the aging brain? We explore their potential role in Alzheimer's disease, Parkinson's disease, memory loss, and cognitive health. We also discuss the hypothalamus, a region of the brain that may play a central role in regulating aging throughout the body.
From epigenetic reprogramming and the Klotho gene to mitochondrial health and regenerative medicine, we examine some of the most promising—and still experimental, approaches to extending brain healthspan.
Can we really reset the brain's biological clock, or are we still at the beginning of understanding how these technologies work?
#EsraÇavuşoğlu #AyıkKafa #ElevatingLifeEvolvingHealth #Longevilab #VincentGiampapa
Dr. Vincent Giampapa, MD
Website: https://drgiampapa.org/
Special thanks to T.C. Istanbul Gedik University https://www.gedik.edu.tr/en/
00:00-04:45 Introduction to Dr. Vincent Giampapa.
04:45-06:35 The Biological Clocks of Aging: Can We Turn Back Time?
06:35-10:07 The Hypothalamus: The Brain's Master Aging Clock
10:07-15:07 Stem Cells, Plasmapheresis & DNA Repair
15:07-16:39 Muse Cells, Exosomes & Cellular Regeneration
16:39-24:24 Epigenetic Reprogramming: Rejuvenating Aging Cells
24:24-29:54 CRISPR, Yamanaka Factors & Cancer Risks
29:54-31:37 Klotho Gene Therapy & Cognitive Function
31:37-37:56 Gene Therapy Results, Safety & Clinical Evidence
37:56-45:00 Mitochondria, NAD+, NMN & Cellular Energy
45:00-50:45 Can We Reset the Hypothalamus Aging Clock?
50:45-58:13 Alzheimer's, Parkinson's & Stroke Recovery Research
58:13-59:15 The 5-Day Brain Protocol: Ultrasound, TMS & Light Therapy
59:15-1:04:01 Reported Results From Cognitive Testing
1:04:01-1:04:51 Wrap up.
*About Ayık Kafa* Dr. Esra Çavuşoğlu, PhD, took her studies, starting from her personal treatment experiences and continuing with her clinical psychology education, to the next level by completing her PhD focused on Addiction. Dr. Esra in Ayık Kafa podcast discusses the world’s latest technologies, protocols, products and research in the fields of Biohacking and Longevity, while sharing first-hand information and experiences about the Disease of Addiction, as well as her latest academic studies.
*About Dr. Esra Çavuşoğlu, PhD* Longevilab’s founder, Dr. Esra, is a United States and internationally trained clinical psychologist and a certified addiction therapist in New York. She served as International Development Advisor on the Yale University Faculty of Medicine Clinical Advisory Board. She is the founder and supervisor of Gaziantep Oya Bahadır Yüksel Rehabilitation Center, Dr. Esra is the designer and implementer of the Turkey Rehabilitation Model. Dr. Esra founded the Contemporary Addiction Studies Association (ÇABAÇAD) in order to combat Turkey’s growing addiction problem.
DisclaimerThe information and statements on our YouTube Channel Sober-Head are not intended to guide individuals towards medical diagnosis and treatment.Please consult with your doctor for medical diagnostic and treatment procedures.The content is shared for informational purposes only, derived from scientific studies prepared by EMC Medya Yayıncılık Ticaret Ltd. Şti.’s researchers, consultants, and authors/scientists, as well as compilations from publicly available public